| LISATA THERAPEUTICS |
| USA |
| Gesundheit |
| US1280583022 / A3DWGC |
| 8NE (Frankfurt) / LSTA (NASDAQ) |
| FRA:8NE, ETR:8NE, 8NE:GR, NASDAQ:LSTA |
| - |
| https://www.lisata.com/ |
|
Lisata Therapeutics Inc. is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other serious diseases. Its lead investigational product, certepeti..
>Volltext.. |
| 39.2 Mio. EUR |
| 25.41 Mio. EUR |
| 0.15 Mio. EUR |
| -15.65 Mio. EUR |
| -14.37 Mio. EUR |
| -1.66 EUR |
| - |
| 13.82 Mio. EUR |
| -13.82 Mio. EUR |
| 5.2 |
| -85.02% |
| 26.85% |
| - |
| - |
| - |
| - |
| LISATA |
| 05.04.26 |
|